Solubilization of nonpolar drugs constitutes one of the most important task
s in parenteral formulations design. This study investigates and assesses t
he solubility enhancement of Fluasterone by various techniques including co
solvency, micellization, and complexation. Of the solubilizing agents used,
the modified beta-cyclodextrins were found to be the most effective. The s
olubility of Fluasterone is 1.55 x 10(-4) mM, 3.13 mM, and 4.04 mM in water
, 20% sulfobutyl ether-beta-cyclodextrin (SBE beta CD), and 20% hydroxyprop
yl-beta-cyciodextrin (HP beta CD), respectively.